blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4061477

EP4061477 - IMPLANTABLE ARRAYS FOR PROVIDING TUMOR TREATING FIELDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.07.2024
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  04.08.2023
FormerGrant of patent is intended
Status updated on  16.04.2023
FormerRequest for examination was made
Status updated on  29.03.2023
FormerGrant of patent is intended
Status updated on  19.03.2023
FormerRequest for examination was made
Status updated on  26.08.2022
FormerThe international publication has been made
Status updated on  29.05.2021
Formerunknown
Status updated on  09.12.2020
Most recent event   Tooltip19.07.2024Lapse of the patent in a contracting state
New state(s): CH
published on 21.08.2024  [2024/34]
Applicant(s)For all designated states
Novocure GmbH
D4 Park 6
6039 Root / CH
[2022/39]
Inventor(s)01 / CARLSON, Kristen W.
3 Nathan Pratt Drive N. 208
Concord, MA 01742 / US
 [2022/39]
Representative(s)Boden, Keith McMurray
Vertus Professional Services Ltd
1 Highlands Road
Reigate, RH2 0LA / GB
[2022/39]
Application number, filing date20816852.619.11.2020
[2022/39]
WO2020US61251
Priority number, dateUS201962938586P21.11.2019         Original published format: US 201962938586 P
US202063085658P30.09.2020         Original published format: US 202063085658 P
[2022/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021102120
Date:27.05.2021
Language:EN
[2021/21]
Type: A1 Application with search report 
No.:EP4061477
Date:28.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2021 takes the place of the publication of the European patent application.
[2022/39]
Type: B1 Patent specification 
No.:EP4061477
Date:06.09.2023
Language:EN
[2023/36]
Search report(s)International search report - published on:EP27.05.2021
ClassificationIPC:A61N1/36, A61N1/05, A61N1/40, A61N1/04
[2022/39]
CPC:
A61N1/36002 (EP); A61N1/0529 (EP); A61N1/36017 (EP);
A61N1/40 (EP); A61N1/0408 (EP); A61N1/0534 (EP);
A61N1/403 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/39]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:IMPLANTIERBARE ANORDNUNGEN ZUR BEREITSTELLUNG VON TUMORBEHANDLUNGSFELDERN[2022/39]
English:IMPLANTABLE ARRAYS FOR PROVIDING TUMOR TREATING FIELDS[2022/39]
French:RÉSEAUX IMPLANTABLES POUR FOURNIR DES CHAMPS DE TRAITEMENT DE TUMEURS[2022/39]
Entry into regional phase14.03.2022National basic fee paid 
14.03.2022Designation fee(s) paid 
14.03.2022Examination fee paid 
Examination procedure14.03.2022Examination requested  [2022/39]
14.03.2022Date on which the examining division has become responsible
01.10.2022Amendment by applicant (claims and/or description)
20.03.2023Communication of intention to grant the patent
28.03.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
17.04.2023Communication of intention to grant the patent
20.04.2023Fee for grant paid
20.04.2023Fee for publishing/printing paid
30.07.2023Receipt of the translation of the claim(s)
Divisional application(s)EP22197055.1  / EP4134127
EP22197081.7  / EP4129397
EP22197121.1  / EP4129398
Opposition(s)07.06.2024No opposition filed within time limit [2024/33]
Fees paidRenewal fee
28.11.2022Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ06.09.2023
ES06.09.2023
HR06.09.2023
MC06.09.2023
PL06.09.2023
RO06.09.2023
RS06.09.2023
SK06.09.2023
SM06.09.2023
CH30.11.2023
NO06.12.2023
GR07.12.2023
IS06.01.2024
[2024/34]
Former [2024/32]CZ06.09.2023
ES06.09.2023
HR06.09.2023
MC06.09.2023
PL06.09.2023
RO06.09.2023
RS06.09.2023
SK06.09.2023
SM06.09.2023
NO06.12.2023
GR07.12.2023
IS06.01.2024
Former [2024/27]CZ06.09.2023
ES06.09.2023
HR06.09.2023
PL06.09.2023
RO06.09.2023
RS06.09.2023
SK06.09.2023
SM06.09.2023
NO06.12.2023
GR07.12.2023
IS06.01.2024
Former [2024/23]CZ06.09.2023
ES06.09.2023
HR06.09.2023
RO06.09.2023
RS06.09.2023
SK06.09.2023
SM06.09.2023
NO06.12.2023
GR07.12.2023
IS06.01.2024
Former [2024/20]HR06.09.2023
RS06.09.2023
SM06.09.2023
NO06.12.2023
GR07.12.2023
IS06.01.2024
Former [2024/11]HR06.09.2023
RS06.09.2023
NO06.12.2023
GR07.12.2023
Former [2024/08]NO06.12.2023
GR07.12.2023
Cited inInternational search[A]WO2007039799  (STANDEN LTD, et al) [A] 1-42 * abstract * * paragraph [0002] - paragraph [0017] * * figures 1-2,5-6 *;
 [XD]US7565205  (PALTI YORAM [IL]) [XD] 1 * the whole document *;
 [A]US2018001075  (KIRSON EILON [IL], et al) [A] 1-42* the whole document *;
 [XAI]WO2018207103  (CARDIO TECH SP Z O O [PL]) [X] 1-6,9,10,12-16,18-20 * the whole document * [A] 7,8,21-42 [I] 11,17;
 [XI]US2019117972  (SCHMIDT BRIAN L [US], et al) [X] 1-6,9,10,12,14,15,18-20 * paragraph [0063] - paragraph [0121] * * figures 1-15 * [I] 11,13,17
by applicantUS7565205
    - DARIA NESTEROVICH et al., "Optimized programming algorithm for cylindrical and directional deep brain stimulation electrodes", Journal of neural engineering, (20180000), vol. 15, no. 2, doi:10.1088/1741-2552/aaa14b, page 026005, XP020325720

DOI:   http://dx.doi.org/10.1088/1741-2552/aaa14b
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.